TRDA
Income statement / Annual
Last year (2023), Entrada Therapeutics, Inc.'s total revenue was $129.01 M,
and the percentage change from the previous year is not available.
In 2023, Entrada Therapeutics, Inc.'s net income was -$6.69 M.
See Entrada Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$129.01 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$99.88 M |
$1.90 M |
$1.12 M |
$326,000.00 |
$104,000.00 |
| Gross Profit |
$29.13 M |
-$1.90 M |
-$1.12 M |
-$326,000.00 |
-$104,000.00 |
| Gross Profit Ratio |
0.23 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$99.88 M
|
$66.61 M
|
$35.93 M
|
$21.10 M
|
$8.22 M
|
| General & Administrative
Expenses |
$32.29 M
|
$30.64 M
|
$15.20 M
|
$5.57 M
|
$3.61 M
|
| Selling & Marketing
Expenses |
-$1.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$32.29 M
|
$30.64 M
|
$15.20 M
|
$5.57 M
|
$3.61 M
|
| Other Expenses |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$6.27 M |
| Operating Expenses |
$132.18 M |
$97.25 M |
$51.13 M |
$26.67 M |
$11.82 M |
| Cost And Expenses |
$132.18 M |
$97.25 M |
$51.13 M |
$26.67 M |
$11.82 M |
| Interest Income |
$15.22 M |
$2.63 M |
$0.00 |
$144,000.00 |
$451,000.00 |
| Interest Expense |
$0.00 |
$2.63 M |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$2.84 M
|
$1.90 M
|
$1.12 M
|
$326,000.00
|
$104,000.00
|
| EBITDA |
-$321,000.00
|
-$95.35 M
|
-$50.01 M
|
-$26.34 M
|
-$11.72 M
|
| EBITDA Ratio |
-0 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
-0.02
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
$15.22 M
|
$2.63 M
|
-$31,000.00
|
$144,000.00
|
$6.72 M
|
| Income Before Tax |
$12.06 M |
-$94.62 M |
-$51.16 M |
-$26.52 M |
-$5.10 M |
| Income Before Tax Ratio
|
0.09
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$18.74 M |
-$7.16 M |
-$1.09 M |
-$144,000.00 |
-$451,000.00 |
| Net Income |
-$6.69 M |
-$87.46 M |
-$50.07 M |
-$26.38 M |
-$4.65 M |
| Net Income Ratio |
-0.05 |
0 |
0 |
0 |
0 |
| EPS |
-0.2 |
-2.79 |
-1.6 |
-0.84 |
-0.15 |
| EPS Diluted |
-0.2 |
-2.79 |
-1.6 |
-0.84 |
-0.15 |
| Weighted Average Shares
Out |
$33.05 M
|
$31.29 M
|
$31.22 M
|
$31.25 M
|
$31.25 M
|
| Weighted Average Shares
Out Diluted |
$33.05 M
|
$31.29 M
|
$31.22 M
|
$31.25 M
|
$31.25 M
|
| Link |
|
|
|
|
|
